Mankind Pharma MANKIND.NS · INR

Its shares trade on NSE under the ticker MANKIND.NS. It has been listed since 9 May 2023. In the fiscal year to 31 March 2026, it reported revenue of ₹142.78bn and net income of ₹19.13bn. At that date it held total assets of ₹280.80bn and shareholders' equity of ₹163.00bn.

Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. The company is headquartered in New Delhi, Delhi. The company went IPO on 2023-05-09. The firm is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Ramesh JunejaExecutive Chairman of the Board, since 1991₹267.9m
• Mr. Prateek DubeyPresident, Global Chief Human Resource Officer
• Mr. Pramod GokhalePresident, Group Chief Information Officer
• Mr. Sheetal AroraChief Executive Officer, Whole-Time Director₹154.1m
• Mr. Rajeev JunejaExecutive Vice Chairman of the Board, Managing Director₹289.0m
• Mr. Ashutosh DhawanChief Financial Officer₹45.9m
• Mr. Prakash AgarwalPresident Strategy
• Dr. Birendra SinghPresident - Global Quality Head
• Mr. Abhay SrivastavaPresident - Operations
• Mr. Farhat UmarPresident - Global Human Resources
• Mr. Arjun JunejaChief Operating Officer, since 2009
• Mr. Atish MajumdarSenior Vice President - Sales and Marketing

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.